Electrosurgical Generator Supplies Safe and Smart Energy
|
By HospiMedica International staff writers Posted on 20 Jun 2018 |

Image: The ESG-300 electrosurgery generator enables advanced therapeutic procedures (Photo courtesy of Olympus Medical).
An intuitive electrosurgery generator enables advanced gastrointestinal (GI) and pulmonary therapeutic procedures, including those that may require argon plasma coagulation.
The Olympus Medical (Olympus; Tokyo, Japan) ESG-300 electrosurgery generator offers an intuitive design that enhances user optimization and overall procedural efficiency. A large, easy to read graphical interface operated via an intuitive touch screen facilitates patients setup and adjustment of physician specific procedures. Precise and easy to read error messages simplify fault handling, along with proven safety features that include a fast spark monitor, high power cut support, a contact quality monitor, and a leakage protection sensor.
One of the key benefits of the ESG-300 is the flexibility of using it either as a stand-alone generator or in combination with the Olympus Medical Argon Plasma Unit (APU-300) in order to produce a variety of waveforms to accommodate monopolar, bipolar, and argon plasma coagulation. A SmartArgon mode detects distance to tissue and adjusts required power automatically, a feature that supports consistent hemostasis with reduced carbonization and limits the penetration depth of the plasma beam.
A foot switch with added automatic foot switch assignment to the generator provides simplified set up and a toggle function to allow physicians to transition efficiently through procedural settings. Together with the ESG-300 and the APU-300, Olympus Medical also offers a wide offering of neutral electrodes, including a variety of sizes and designs, skin-friendly surface, and a split-design with hydrogel, which are designed to minimize the risk of pad site burns and to provide optimum skin contact.
“Our complete range of solutions for the GI and pulmonary segments strengthens our position as a full service provider, and gives our customers room to focus increasingly on therapeutic procedures enabled by energy-driven technology,” said Kurt Heine, group vice president of Olympus America. “We are excited to enter into the argon plasma coagulation market and pleased to complete our family of generator offerings. In partnership with our customers, we continue to drive increased quality of care, cost reductions, and patient satisfaction.”
The Olympus Medical (Olympus; Tokyo, Japan) ESG-300 electrosurgery generator offers an intuitive design that enhances user optimization and overall procedural efficiency. A large, easy to read graphical interface operated via an intuitive touch screen facilitates patients setup and adjustment of physician specific procedures. Precise and easy to read error messages simplify fault handling, along with proven safety features that include a fast spark monitor, high power cut support, a contact quality monitor, and a leakage protection sensor.
One of the key benefits of the ESG-300 is the flexibility of using it either as a stand-alone generator or in combination with the Olympus Medical Argon Plasma Unit (APU-300) in order to produce a variety of waveforms to accommodate monopolar, bipolar, and argon plasma coagulation. A SmartArgon mode detects distance to tissue and adjusts required power automatically, a feature that supports consistent hemostasis with reduced carbonization and limits the penetration depth of the plasma beam.
A foot switch with added automatic foot switch assignment to the generator provides simplified set up and a toggle function to allow physicians to transition efficiently through procedural settings. Together with the ESG-300 and the APU-300, Olympus Medical also offers a wide offering of neutral electrodes, including a variety of sizes and designs, skin-friendly surface, and a split-design with hydrogel, which are designed to minimize the risk of pad site burns and to provide optimum skin contact.
“Our complete range of solutions for the GI and pulmonary segments strengthens our position as a full service provider, and gives our customers room to focus increasingly on therapeutic procedures enabled by energy-driven technology,” said Kurt Heine, group vice president of Olympus America. “We are excited to enter into the argon plasma coagulation market and pleased to complete our family of generator offerings. In partnership with our customers, we continue to drive increased quality of care, cost reductions, and patient satisfaction.”
Latest Surgical Techniques News
- Fiber-Form Bone Graft Expands Intraoperative Options for Spinal Fusion
- Ultrasound‑Aided Catheter Treatment Cuts Early Collapse in Pulmonary Embolism
- Ultrasound Technology Aims to Replace Invasive BPH Procedures
- Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
- New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
- Robot-Assisted Brain Angiography Improves Procedural Outcomes
- Brain Mapping Technology Enhances Precision in Brain Tumor Resection
- Handheld Robotic System Expands Options for Total Knee Surgery
- VR Experience Reduces Patient Anxiety Before Kidney Stone Procedure
- Injectable Mini Livers Offer Hope for Patients Awaiting Transplant
- Pulsed Field Ablation Technology Cleared in Europe for Persistent AFib
- AI-Powered Imaging Brings Real-Time Margin Clarity to Breast Cancer Surgery
- Minimally Invasive Device Safely Treats Challenging Brain Aneurysms
- Surgical Robot Makes Complex Liver Tumor Surgery Safer and Less Invasive
- Neurostimulation Implant Reduces Seizure Burden in Drug-Resistant Epilepsy
- Minimally Invasive Procedure Effectively Treats Small Kidney Cancers
Channels
Artificial Intelligence
view channelAI Analysis of Pericardial Fat Refines Long-Term Heart Disease Risk
Accurately identifying long-term cardiovascular disease risk in asymptomatic adults remains challenging for clinicians. Missed or underestimated risk delays preventive therapy and increases the chance... Read more
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read moreCritical Care
view channel
Angiography-Based FFR Approach Matches Gold Standard Results Without Wires
Accurately determining whether a coronary stenosis limits blood flow is essential to guide percutaneous coronary intervention, yet wire-based physiologic testing remains underused due to added procedural... Read more
Eye Imaging AI Identifies Elevated Cardiovascular Risk
Many adults at risk for atherosclerotic cardiovascular disease are not identified until they undergo formal primary care assessment. Delayed risk recognition can postpone initiation of statins and lifestyle... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
Voice-Driven AI System Enables Structured GI Procedure Documentation
Documentation during gastrointestinal (GI) procedures often competes with real-time clinical decision-making and imposes a significant cognitive burden on physicians. Manual data entry and post-procedure... Read more
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel







